Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease

Our results suggest that differential levels of sSorLA in CSF could be used as a novel marker to explore disrupted trafficking of SorLA protein in Alzheimer disease. This could help solve some proportion of variants of uncertain significance in SORL1.

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-05-07
DOI
https://doi.org/10.1186/s13195-025-01748-0
Citations
1
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease

Olivier Bousiges, Gwenaël Le Guyader, David Wallon, Magalie Lecourtois et al.
1 citations
Alzheimer s Research & Therapy
Alzheimer's disease research and treatments
1.16
article

Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease

Olivier Bousiges, Gwenaël Le Guyader, David Wallon, Magalie Lecourtois, Anne Beaume, Julien Dumurgier, Muriel Quillard‐Muraine, Isabelle Quadrio, Maïté Formaglio, Susanna Schraen, Adeline Rollin‐Sillaire, Catherine Schramm, Gaël Nicolas, Anne Rovelet‐Lecrux, Frédéric Blanc, Aline Zaréa, Sylvain Lehmann, Jérémie Pariente, Cécilia Marelli, Matthieu Martinet, Léonor Nogueira, Romain Castelot
article en
1 citations

Abstract

Our results suggest that differential levels of sSorLA in CSF could be used as a novel marker to explore disrupted trafficking of SorLA protein in Alzheimer disease. This could help solve some proportion of variants of uncertain significance in SORL1.

Alzheimer s Research & TherapyVol. 17(1)
Université Claude Bernard Lyon 1 (FR), Centre National de la Recherche Scientifique (FR), Université Toulouse III - Paul Sabatier (FR), Inserm (FR), École Pratique des Hautes Études (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université de Montpellier (FR), Université Paris Cité (FR), Université de Lille (FR), Institut Pasteur de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Centre Hospitalier Universitaire de Toulouse (FR), Centre Hospitalier Universitaire de Montpellier (FR), Centre de Recherche en Neurosciences de Lyon (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Normandie Université (FR), Centre Hospitalier Universitaire de Poitiers (FR), Hôpital Lariboisière (FR), Centre Hospitalier Universitaire de Rouen (FR), Hôpital d'Hautepierre (FR), Université de Rouen Normandie (FR), Université de Strasbourg (FR)
European Commission, FONDATION ALZHEIMER, European Regional Development Fund
Gender equality
Openalex Percentile: Top 23%
Alzheimer's disease research and treatments
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.